title: Chronic lymphocytic leukemia: treatment of relapse.
abstract: Despite significant advances in the frontline treatment of chronic lymphocytic leukemia (CLL), patients eventually experience disease progression. Treatment selection of relapsed disease depends upon a variety of factors, including patient age, performance status, duration of response to initial therapy, type of prior therapy, disease-related manifestations and genetic abnormalities within the CLL cells. This presentation offers synthetic overview of the options in this field.
authors.affiliation: Department of Onco-Hematology, Division of Hematology, Niguarda Ca' Granda Hospital , Milano, Italy.
authors.forename: M
authors.initials: M
authors.lastname: Montillo
keywords: allogeneic transplant; chemoimmunotherapy; chronic lymphocytic leukemia; monoclonal antibodies; relapse; resistance to purine analogs